Dr. Giada Bianchi is a senior fellow in the Hematologic Neoplasia division and a researcher in the LeBow Institute for Myeloma Therapeutics/Jerome Lipper Multiple Myeloma Center at Dana Farber Cancer Institute in Boston, MA. She received her medical degree at the “Vita-Salute” San Raffaele University in Milan, Italy, with a thesis on the molecular mechanisms underlying sensitivity of multiple myeloma cells to proteasome inhibitors. She accomplished further research training with Alfred L. Goldberg, PhD, at the Harvard Medical School, and Kenneth C. Anderson, MD, at the Dana Farber Cancer Institute, Boston, MA.
Dr. Bianchi graduated from the Internal Medicine Residency program at the Mayo Clinic, Rochester, MN, where she pursued clinical and translational research in multiple myeloma with Vincent S. Rajkumar, MD, and Shaji Kumar, MD, respectively. She then completed a fellowship in Hematology/Oncology at the Dana Farber Cancer Institute/Partners where she is anticipated to join the staff shortly.
Dr. Bianchi’s research focuses on the molecular mechanisms underlying the transformation of premalignant plasma cell dyscrasia, monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM), into active multiple myeloma. In her short career, she authored over 20 articles and 4 book chapters in the field of multiple myeloma. She is the recipient of the Friends of Dana Farber’s Fellow Award, 2013; the Janock Fellow Award, 2014, the Kenneth Anderson Award in Hematologic Oncology, 2015 and the American Society of Hematology (ASH) Research Training Award for Fellows, 2015.